Recruitment

Recruitment Status
Unknown status

Inclusion Criterias

if on psychiatric medication, must be on a stable dose
clinical diagnosis of borderline personality disorder
18 years or older
...
if on psychiatric medication, must be on a stable dose
clinical diagnosis of borderline personality disorder
18 years or older
able to swallow tablets

Exclusion Criterias

Conditions that can affect immune system functioning.
Impaired liver function (> 1.25x the upper limit of the reference range)
pregnancy
...
Conditions that can affect immune system functioning.
Impaired liver function (> 1.25x the upper limit of the reference range)
pregnancy
suicidal ideation or behavior requiring imminent inpatient treatment
current eating disorder
current, primary substance abuse, particularly alcoholism
Participants whose medication has not been stable for more than 4 weeks
history or current psychotic disorder

Summary

Conditions
Borderline Personality Disorder
Type
Interventional
Phase
Phase 2
Design
  • Allocation: Non-Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Basic Science

Participation Requirements

Age
Between 18 years and 50 years
Gender
Only females

Inclusion Criterias

if on psychiatric medication, must be on a stable dose
clinical diagnosis of borderline personality disorder
18 years or older
...
if on psychiatric medication, must be on a stable dose
clinical diagnosis of borderline personality disorder
18 years or older
able to swallow tablets

Exclusion Criterias

Conditions that can affect immune system functioning.
Impaired liver function (> 1.25x the upper limit of the reference range)
pregnancy
...
Conditions that can affect immune system functioning.
Impaired liver function (> 1.25x the upper limit of the reference range)
pregnancy
suicidal ideation or behavior requiring imminent inpatient treatment
current eating disorder
current, primary substance abuse, particularly alcoholism
Participants whose medication has not been stable for more than 4 weeks
history or current psychotic disorder

Locations

Columbus, Ohio, 43210
Columbus, Ohio, 43210

Tracking Information

NCT #
NCT02108990
Collaborators
National Center for Advancing Translational Science (NCATS)
Investigators
  • Principal Investigator: Baldwin M Way, Ph.D. Ohio State University Principal Investigator: Jennifer S. Cheavens, Ph.D. Ohio State University
  • Baldwin M Way, Ph.D. Ohio State University Principal Investigator: Jennifer S. Cheavens, Ph.D. Ohio State University